Retrovolution: HIV-Driven Evolution of Cellular Genes and Improvement of Anticancer Drug Activation

PLoS Genetics

Volumn 8, Issue 8, 2012, Pages

  Rossolillo, Paola ^a   Winter, Flore ^a   Simon Loriere, Etienne ^a,b   Gallois Montbrun, Sarah ^c,d,e   Negroni, Matteo ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE KINASE; GEMCITABINE; GENOMIC RNA; NUCLEOSIDE DERIVATIVE; RETROVIRUS VECTOR; DEOXYCYTIDINE; DRUG DERIVATIVE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CANCER GENE THERAPY; CELL ISOLATION; CELL STRAIN HEK293; CELL VIABILITY; CHEMOSENSITIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEOXYCYTIDINE KINASE GENE; ENZYME ACTIVE SITE; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; FEMALE; GENE ACTIVATION; GENE DIRECTED ENZYME PRODRUG THERAPY; GENE IDENTIFICATION; GENE INSERTION; GENE LIBRARY; GENE MUTATION; GENE TARGETING; GENE TECHNOLOGY; GENETIC SCREENING; GENETIC TRANSDUCTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MICROBIOLOGICAL PARAMETERS; MULTIPLICITY OF INFECTION; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; RETROVOLUTION SYSTEM; SUICIDE GENE; TRANSGENE; TUMOR CELL LINE; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; GENETICS; METHODOLOGY; MOLECULAR GENETICS; MUTATION; NEOPLASM; SEQUENCE ALIGNMENT; VESICULAR STOMATITIS VIRUS;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; DEOXYCYTIDINE; GENE TARGETING; GENETIC VARIATION; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ALIGNMENT; VESICULOVIRUS;

EID: 84866150105     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002904     Document Type: Article

References (38)

1. Christians FC, Scapozza L, Crameri A, Folkers G, Stemmer WP, (1999) Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling. Nat Biotechnol 17: 259-264.
2. Mansky LM, (1998) Retrovirus mutation rates and their role in genetic variation. J Gen Virol 79: 1337-1345.
3. Mansky LM, Temin HM, (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69: 5087-5094.
4. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH, (2010) Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol 84: 9864-9878.
5. Hu WS, Temin HM, (1990) Retroviral recombination and reverse transcription. Science 250: 1227-1233.
6. Onafuwa-Nuga A, Telesnitsky A, (2009) The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev 73: 451-480.
7. Das AT, Zhou X, Vink M, Klaver B, Verhoef K, et al. (2004) Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J Biol Chem 279: 18776-18782.
8. Davis JN, van den Pol AN, (2010) Viral mutagenesis as a means for generating novel proteins. J Virol 84: 1625-1630.
9. Wang L, Jackson WC, Steinbach PA, Tsien RY, (2004) Evolution of new nonantibody proteins via iterative somatic hypermutation. Proc Natl Acad Sci U S A 101: 16745-16749.
10. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W, (1991) Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51: 6110-6117.
11. Van Rompay AR, Johansson M, Karlsson A, (2003) Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases. Pharmacol Ther 100: 119-139.
12. Hapke DM, Stegmann AP, Mitchell BS, (1996) Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity. Cancer Res 56: 2343-2347.
13. Jordheim LP, Galmarini CM, Dumontet C, (2006) Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells. Cancer Chemother Pharmacol 58: 547-554.
14. Tanaka M, Javle M, Dong X, Eng C, Abbruzzese JL, et al. (2010) Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer. Cancer 116: 5325-5335.
15. Jordheim LP, Dumontet C, (2007) Review of recent studies on resistance to cytotoxic deoxynucleoside analogues. Biochim Biophys Acta 1776: 138-159.
16. Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, et al. (2003) Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Ther 10: 353-364.
17. Rainov NG, (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401.
18. Manome Y, Wen PY, Dong Y, Tanaka T, Mitchell BS, et al. (1996) Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med 2: 567-573.
19. Sabini E, Ort S, Monnerjahn C, Konrad M, Lavie A, (2003) Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. Nat Struct Biol 10: 513-519.
20. McSorley T, Ort S, Hazra S, Lavie A, Konrad M, (2008) Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues. FEBS Lett 582: 720-724.
21. Drummond DA, Silberg JJ, Meyer MM, Wilke CO, Arnold FH, (2005) On the conservative nature of intragenic recombination. Proc Natl Acad Sci U S A 102: 5380-5385.
22. Galetto R, Negroni M, (2005) Mechanistic features of recombination in HIV. AIDS Rev 7: 92-102.
23. Kim T, Mudry RA Jr, Rexrode CA 2nd, Pathak VK, (1996) Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol 70: 7594-7602.
24. Funamizu N, Okamoto A, Kamata Y, Misawa T, Uwagawa T, et al. (2010) Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? Oncol Rep 23: 471-475.
25. Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis I, et al. (2002) Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol Cancer Ther 1: 371-376.
26. Hazra S, Szewczak A, Ort S, Konrad M, Lavie A, (2011) Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release. Biochemistry 50: 2870-2880.
27. Gutierrez-Rivas M, Menendez-Arias L, (2001) A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis. Nucleic Acids Res 29: 4963-4972.
28. Mansky LM, Le Rouzic E, Benichou S, Gajary LC, (2003) Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. J Virol 77: 2071-2080.
29. Burt RK, Drobyski WR, Seregina T, Traynor A, Oyama Y, et al. (2003) Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions. Exp Hematol 31: 903-910.
30. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, et al. (1996) T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 2: 216-223.
31. Sabini E, Hazra S, Ort S, Konrad M, Lavie A, (2008) Structural basis for substrate promiscuity of dCK. J Mol Biol 378: 607-621.
32. Giver L, Gershenson A, Freskgard PO, Arnold FH, (1998) Directed evolution of a thermostable esterase. Proc Natl Acad Sci U S A 95: 12809-12813.
33. Petrounia IP, Arnold FH, (2000) Designed evolution of enzymatic properties. Curr Opin Biotechnol 11: 325-330.
34. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D, (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
35. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
36. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, et al. (1994) A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A 91: 9564-9568.
37. Agarwal KC, Miech RP, Parks RE Jr, (1978) Guanylate kinases from human erythrocytes, hog brain, and rat liver. Methods Enzymol 51: 483-490.
38. Sabini E, Hazra S, Konrad M, Lavie A, (2007) Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides. J Med Chem 50: 3004-3014.